Marlborough biotech manufacturer ReWalk Robotics’ stock skyrocketed Wednesday, rising more than 180% after the company announced FDA clearance of one of ReWalk's main products.
Marlborough cardiac device firm CardioFocus has completed a $55-million round of financing intended to accelerate the commercial introduction of a new generation of its flagship product.Â
The U.S. Food and Drug Administration has approved the first two tests to detect certain sexually transmitted infections outside of the genitals, and one of those tests belongs to Marlborough medical device maker Hologic.Â
More than $12 billion in federal funding for public health programs in Massachusetts could be at risk by a proposed rule that Attorney General Maura Healey sued to block on Tuesday.
Four Central Massacusetts cities — Framingham, Gardner, Marlborough and Worcester — are bucking a state trend that is generally showing fewer opioid-related deaths.